The Medical Alley Association announced today that it appointed Roberta Dressen as its new president and CEO.
Dressen takes over the position previously held by Shaye Mandle since 2014 before he announced his departure for the Biotechnology Innovation Organization (BIO) in February. Steffen Hovard served as interim CEO in the time since then.
Hovard will stay on board over the next several weeks to assist with the transition as Dressen officially begins her new role next week, according to a news release.
“The Medical Alley Association has a strong reputation of leadership and innovation,” Dressen said in the release. “I look forward to joining MAA and partnering with other global healthcare leaders to find ways to better serve our members and stimulate collaboration around how we can bridge current gaps in the healthcare industry.”
Dressen holds nearly two decades of leadership experience with some of Medical Alley’s notable healthcare organizations, including Allina Health, UnitedHealth Group, Boston Scientific and Medtronic. She currently serves as an operating partner at LFE Capital, a private equity firm investing in women-led wellness companies.
“MAA’s board of directors is excited to begin working with Roberta Dressen,” said Medical Alley Board Chair Jim Rogers, who is also Mayo Clinic’s chief business development officer. “Her experience will help MAA continue to be one of the most influential healthcare organizations in the world.”